RESUMEN
The period (per) gene likely encodes a component of the Drosophila circadian clock. Circadian oscillations in the abundance of per messenger RNA and per protein (PER) are thought to arise from negative feedback control of per gene transcription by PER. A recently identified second clock locus, timeless (tim), apparently regulates entry of PER into the nucleus. Reported here are the cloning of complementary DNAs derived from the tim gene in a two-hybrid screen for PER-interacting proteins and the demonstration of a physical interaction between the tim protein (TIM) and PER in vitro. A restricted segment of TIM binds directly to a part of the PER dimerization domain PAS. PERL, a mutation that causes a temperature-sensitive lengthening of circadian period and a temperature-sensitive delay in PER nuclear entry, exhibits a temperature-sensitive defect in binding to TIM. These results suggest that the interaction between TIM and PER determines the timing of PER nuclear entry and therefore the duration of part of the circadian cycle.
Asunto(s)
Ritmo Circadiano/genética , Proteínas de Drosophila , Drosophila melanogaster/metabolismo , Proteínas Nucleares/metabolismo , Proteínas/metabolismo , Animales , Relojes Biológicos/genética , Núcleo Celular/metabolismo , Clonación Molecular , Citoplasma/metabolismo , ADN Complementario/genética , Drosophila melanogaster/genética , Retroalimentación , Regulación de la Expresión Génica , Genes de Insecto , Mutación , Proteínas Nucleares/genética , Proteínas Circadianas Period , Proteínas/genética , Proteínas/aislamiento & purificación , Proteínas Recombinantes de Fusión/metabolismo , TemperaturaRESUMEN
The mouse Clock gene encodes a bHLH-PAS protein that regulates circadian rhythms and is related to transcription factors that act as heterodimers. Potential partners of CLOCK were isolated in a two-hybrid screen, and one, BMAL1, was coexpressed with CLOCK and PER1 at known circadian clock sites in brain and retina. CLOCK-BMAL1 heterodimers activated transcription from E-box elements, a type of transcription factor-binding site, found adjacent to the mouse per1 gene and from an identical E-box known to be important for per gene expression in Drosophila. Mutant CLOCK from the dominant-negative Clock allele and BMAL1 formed heterodimers that bound DNA but failed to activate transcription. Thus, CLOCK-BMAL1 heterodimers appear to drive the positive component of per transcriptional oscillations, which are thought to underlie circadian rhythmicity.
Asunto(s)
Ritmo Circadiano/fisiología , Proteínas Nucleares/genética , Transactivadores/metabolismo , Factores de Transcripción/metabolismo , Activación Transcripcional , Factores de Transcripción ARNTL , Animales , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico , Relojes Biológicos , Proteínas CLOCK , Proteínas de Ciclo Celular , Ritmo Circadiano/genética , Clonación Molecular , Cricetinae , ADN/metabolismo , Dimerización , Retroalimentación , Expresión Génica , Secuencias Hélice-Asa-Hélice , Masculino , Mesocricetus , Ratones , Mutación , Proteínas Nucleares/metabolismo , Proteínas Circadianas Period , Regiones Promotoras Genéticas , Retina/metabolismo , Núcleo Supraquiasmático/metabolismo , Transactivadores/genética , Factores de Transcripción/genéticaRESUMEN
The circadian oscillator generates a rhythmic output with a period of about 24 hours. Despite extensive studies in several model systems, the biochemical mode of action has not yet been demonstrated for any of its components. Here, the Drosophila CLOCK protein was shown to induce transcription of the circadian rhythm genes period and timeless. dCLOCK functioned as a heterodimer with a Drosophila homolog of BMAL1. These proteins acted through an E-box sequence in the period promoter. The timeless promoter contains an 18-base pair element encompassing an E-box, which was sufficient to confer dCLOCK responsiveness to a reporter gene. PERIOD and TIMELESS proteins blocked dCLOCK's ability to transactivate their promoters via the E-box. Thus, dCLOCK drives expression of period and timeless, which in turn inhibit dCLOCK's activity and close the circadian loop.
Asunto(s)
Ritmo Circadiano/fisiología , Proteínas de Drosophila , Proteínas de Insectos/genética , Proteínas Nucleares/genética , Transactivadores/metabolismo , Factores de Transcripción/metabolismo , Activación Transcripcional , Factores de Transcripción ARNTL , Animales , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico , Relojes Biológicos , Proteínas CLOCK , Línea Celular , Núcleo Celular/metabolismo , Ritmo Circadiano/genética , Dimerización , Drosophila , Retroalimentación , Expresión Génica , Secuencias Hélice-Asa-Hélice , Proteínas de Insectos/metabolismo , Proteínas Nucleares/metabolismo , Proteínas Circadianas Period , Regiones Promotoras Genéticas , ARN Mensajero/genética , ARN Mensajero/metabolismo , Transactivadores/genética , Factores de Transcripción/genética , TransfecciónRESUMEN
We report the cloning and mapping of mouse (mTim) and human (hTIM) orthologs of the Drosophila timeless (dtim) gene. The mammalian Tim genes are widely expressed in a variety of tissues; however, unlike Drosophila, mTim mRNA levels do not oscillate in the suprachiasmatic nucleus (SCN) or retina. Importantly, hTIM interacts with the Drosophila PERIOD (dPER) protein as well as the mouse PER1 and PER2 proteins in vitro. In Drosophila (S2) cells, hTIM and dPER interact and translocate into the nucleus. Finally, hTIM and mPER1 specifically inhibit CLOCK-BMAL1-induced transactivation of the mPer1 promoter. Taken together, these results demonstrate that mTim and hTIM are mammalian orthologs of timeless and provide a framework for a basic circadian autoregulatory loop in mammals.
Asunto(s)
Ritmo Circadiano/genética , Proteínas de Drosophila , Proteínas de Insectos/fisiología , Proteínas Nucleares/metabolismo , Transactivadores/genética , Factores de Transcripción/genética , Factores de Transcripción/fisiología , Factores de Transcripción ARNTL , Empalme Alternativo/genética , Secuencia de Aminoácidos , Animales , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico , Relojes Biológicos/genética , Proteínas CLOCK , Proteínas de Ciclo Celular , Línea Celular , Mapeo Cromosómico , Cromosomas Humanos Par 12/genética , Clonación Molecular , Drosophila , Femenino , Humanos , Proteínas de Insectos/genética , Proteínas de Insectos/metabolismo , Péptidos y Proteínas de Señalización Intracelular , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Proteínas Nucleares/fisiología , Proteínas Circadianas Period , Polimorfismo Genético , ARN Mensajero/biosíntesis , Transactivadores/antagonistas & inhibidores , Factores de Transcripción/metabolismoRESUMEN
The muscle-specific isoform of phosphofructokinase (PFK-A) is induced during muscle development. To understand expression of PFK at the molecular level, transcription of the mouse PFK-A gene was examined during C2 myoblast differentiation to myotubes. PFK-A gene transcription increased 5-7-fold during differentiation in vitro. To identify cis-acting elements which direct muscle-specific transcription of the PFK-A gene, its 5'-flanking region and first exon were cloned and characterized. S1 nuclease protection and primer extension assays showed four sites of transcription initiation at 106, 105, 88, and 87 bp upstream of the translation initiation codon. Stable transfection of fusion genes linking -1900 to +99 of PFK-A 5'-flanking sequence to chloramphenicol acetyltransferase coding sequences into myogenic C2 cells did not confer muscle-specific expression. However, larger fragments of PFK-A 5'-flanking region (-5800 to +99) showed muscle-specific expression by transient transfection assay. The sequences directing muscle-specific transcription were further defined by linking various PFK-A upstream fragments to the luciferase gene under the control of the PFK-A proximal promoter, -335 to +99 bp. We found DNA sequence responsible for muscle-specific expression of the PFK-A gene between -4800 and -3900 bp.
Asunto(s)
Diferenciación Celular , Regulación Enzimológica de la Expresión Génica , Músculos/citología , Fosfofructoquinasa-1/genética , Animales , Secuencia de Bases , Células Cultivadas , Cloranfenicol O-Acetiltransferasa/genética , Clonación Molecular , Codón , Exones , Ratones , Datos de Secuencia Molecular , Desarrollo de Músculos , Músculos/enzimología , Regiones Promotoras Genéticas , Proteínas Recombinantes de Fusión , Mapeo Restrictivo , Transcripción Genética , TransfecciónRESUMEN
Isozyme expression of phosphofructokinase (PFK), the key regulatory enzyme for glycolysis, was studied during differentiation of mouse C2 myoblasts to myotubes. The total PFK activity increased 20-fold during in vitro myogenesis. The rate of synthesis, relative to the rate of total protein synthesis, measured by pulse labeling and immunoprecipitation was lowest for muscle PFK (PFK-A), 0.008% in myoblasts, while those for liver (PFK-B) and brain (PFK-C) PFK were 0.017 and 0.014%, respectively. The relative rate of PFK-A synthesis increased sharply (5-fold) at an initial period of differentiation (8 h) and reached maximum of 10-fold at 48 h, to make PFK-A the major isoform synthesized in myotubes. The relative rates of synthesis for both PFK-B and PFK-C did not change drastically, decreasing slightly at 8 h, but were restored to 1.5-2-fold of myoblasts. cDNA sequences coding for mouse muscle PFK were cloned and used along with those for mouse liver PFK, which we have previously cloned, to measure by Northern blot analysis under highly stringent conditions the steady-state mRNA concentrations for muscle and liver PFK during C2 differentiation. The hybridizable mRNA level for PFK-A increased gradually, reaching 13-fold at 48 h when 80% of cells was fused to myotubes. The PFK-A mRNA level at 96 h was 90-fold of that for myoblasts. In contrast, the mRNA level for PFK-B increased slightly during differentiation, showing a maximum of 4-fold at 96 h. These results indicate isozyme-specific control of muscle PFK gene expression during C2 myoblast differentiation.
Asunto(s)
Isoenzimas/metabolismo , Músculos/enzimología , Fosfofructoquinasa-1/metabolismo , Animales , Encéfalo/enzimología , Diferenciación Celular , Línea Celular , ADN/genética , Regulación de la Expresión Génica , Glucólisis , Hígado/enzimología , Ratones , Músculos/citología , ARN Mensajero/genéticaRESUMEN
Mouse liver mRNA enriched in sequences coding for liver phosphofructokinase by polysome immunoadsorption was used as a template for the synthesis of cDNA. The double-stranded cDNA was inserted into the expression vector lambda gt11 and cloned. Preliminary identification of clones containing cDNA sequences for phosphofructokinase was made by screening the library with anti-rat liver phosphofructokinase serum and horseradish peroxidase-conjugated goat anti-rabbit IgG as second antibody. Subsequently, by selecting antibodies specific to fusion proteins expressed by putative clones and by reacting with Western blots of mouse liver proteins several clones were positively identified as containing liver phosphofructokinase sequences. A cDNA clone corresponding to 2708 nucleotides of liver phosphofructokinase mRNA was further characterized and sequenced. The liver phosphofructokinase mRNA has an open reading frame of 2343 nucleotides followed by a 3'-untranslated region of 303 nucleotides. The G/C-rich (76%) portion of the 5'-untranslated region precedes a characteristic translational start site of CCGCC(AUG). The mRNA coding sequence indicates that the liver phosphofructokinase subunit is composed of 780 amino acid residues and has a Mr of 85,000. Comparison of the deduced amino acid sequence of mouse liver phosphofructokinase with the known rabbit muscle phosphofructokinase shows 68% homology. The N-half of the liver phosphofructokinase has conserved substrate binding sites for ATP and fructose-6-P. The 25 C-terminal residues, which contain the ATP inhibitory site, are the least homologous (20%) but contain a putative phosphorylation site (Arg-Arg-X-X-Ser). The liver phosphofructokinase mRNA is under nutritional and hormonal regulation. The liver phosphofructokinase mRNA level increased 4-fold when previously starved mice were refed a high carbohydrate, fat-free diet. This increase in mRNA level was blocked by 50% by the administration of dibutyryl cAMP. The induction of liver phosphofructokinase mRNA by fasting/refeeding was also diminished in streptozotocin diabetic mice.
Asunto(s)
Hígado/enzimología , Fosfofructoquinasa-1/genética , ARN Mensajero/genética , Secuencia de Aminoácidos , Animales , Bacteriófago lambda/genética , Secuencia de Bases , Clonación Molecular , ADN/genética , ADN Recombinante , Técnicas para Inmunoenzimas , Ratones , Datos de Secuencia Molecular , Biosíntesis de Proteínas , Conejos , Ratas , Homología de Secuencia de Ácido NucleicoRESUMEN
To elucidate the structure, tissue-specific expression, and allosteric properties of phosphofructokinase-C (PFK-C), we cloned the cDNA for PFK-C from a rat hypothalamic cDNA library. The cDNA is 2643 base pairs long and encodes a protein of 765 amino acids. The deduced amino acid sequence is highly homologous to PFK-M (muscle) and PFK-L (liver), 69 and 65% amino acid identity, respectively, especially at substrate binding and catalytic sites, while the allosteric binding sites are less conserved. Tissue-specific expression of PFK-C was investigated by Northern blot analysis. PFK-C mRNA was detected in several brain regions and the anterior pituitary but not in liver, skeletal muscle, or several other tissues. In situ hybridization showed that PFK-C is expressed at a higher level in higher brain regions such as the cortex, compared with the midbrain and basal ganglia, while PFK-L is expressed at approximately equal levels throughout the brain. Expression plasmids containing PFK-C and PFK-L coding sequences were constructed and expressed by transient transfection into CMT cells. Expression of transfected PFKs was demonstrated by PFK enzymatic activity and by Western blotting with anti-rat brain and liver PFK antisera. Allosteric regulatory properties of PFK-C and PFK-L expressed in CMT cells were compared. Fructose 2,6-bisphosphate, a potent activator of PFK, decreased the Km of PFK-C for fructose 6-phosphate from 200 to 60 microM while decreasing that of PFK-L from 300 to 55 microM. The properties of PFK-C and PFK-L expressed in CMT cells clearly demonstrate the allosteric differences between the different PFK isozymes.